International Companies
International Paper posts strong quarter, reviews GCF business
International Paper posted strong third-quarter results on Thursday, reporting adjusted earnings of 44 cents per share, surpassing the Zacks consensus estimate of 24 cents by 83%.
Merck tops Q3 earnings forecasts despite slower Gardasil demand
Pharmaceuticals firm Merck reported a solid third quarter on Thursday, with revenue up 4% year-over-year to $16. 7bn, driven by robust sales of its cancer drug Keytruda, although muted demand for the Gardasil HPV vaccine remained a challenge.
Danske Bank ups guidance after bumper third quarter
Danske Bank boosted its full-year outlook on Thursday, after third-quarter earnings at Denmark’s biggest lender smashed expectations.
BNP Paribas net income grows as core business faces challenges
BNP Paribas shares were in the red on Thursday morning, after it reported third-quarter net income of €2. 87bn, marking a 5. 9% year-on-year increase, amid challenges in its core lending business and a mixed performance from investment banking.
Stellantis Q3 sales tank as US inventory reduction continues
Shares in Italian-American auto giant Stellantis edged higher on Thursday after a big drop in third-quarter revenues wasn't as bad as feared, as the company works to cut inventory levels at US dealerships.
SocGen reshuffles management as Q3 numbers beat forecasts
French lender Societe Generale posted better-than-expected quarterly profits on Thursday, as it unveiled a shake-up of senior management.
Beer volumes disappoint at AB InBev
Shares in Anheuser-Busch InBev came under pressure on Thursday, after the brewing giant posted a sharper-than-expected drop in beer volumes.
China manufacturing activity expands for first time in six months
Manufacturing activity in China expanded in October for the first time since April, according to figures released on Thursday by the National Bureau of Statistics.
Eli Lilly's quarterly numbers disappoint, shares tumble
Shares in Eli Lilly & Co fell sharply on Wednesday, after the US drugs firm missed quarterly forecasts and cut its full-year outlook.
Campari tumbles on Q3 results
Campari shares tumbled on Wednesday after the Italian drinks maker reported a drop in third-quarter profits.
Eurozone GDP surprises on the upside
Eurozone economic growth accelerated in the third quarter, official data showed on Wednesday, beating expectations.
Third-quarter numbers smash expectations at UBS
UBS posted better-than-expected quarterly numbers on Wednesday, after the Swiss bank benefited from a strong performance in the Americas and Asia and an ongoing cost-cutting programme.
Profits, sales plunge at Volkswagen
Profits tumbled at Volkswagen, the German manufacturer confirmed on Wednesday, dragged down by challenging market conditions and higher costs.
Royal Caribbean posts solid third quarter but more cautious outlook
Shares in Miami-based cruise operator Royal Caribbean were sliding in early trading on Tuesday, even after it reported adjusted third-quarter earnings per share of $5. 20, surpassing analyst expectations of $5. 04.
McDonald's tops Q3 forecasts, but international sales narrow
McDonald's reported third-quarter 2024 earnings that surpassed Wall Street expectations on Tuesday, driven by effective US sales strategies, but weighed down by international challenges.
Adidas upbeat after solid third quarter
Adidas reported robust third-quarter earnings on Tuesday, with 10% currency-neutral revenue growth driven by the underlying brand, which rose 14%.
Pfizer lifts full-year guidance on bumper Q3 sales
Pfizer lifted its full-year guidance on Tuesday after third-quarter numbers beat Wall Street expectations.
Lufthansa sees record quarterly sales, but profits slip
German flag carrier Deutsche Lufthansa reported record sales in the third quarter and said winter bookings were above last year, though profits were nearly a tenth lower than last yearT.
Santander shares drop despite Q3 beat as UK results delayed
Shares in Banco Santander slumped on Tuesday despite record third-quarter profits beating analysts' forecasts, as the Spanish banking group announced it was delaying the results of its UK unit owing to this week's landmark ruling on motor finance commissions.
Weaker sales of key drugs leads to mixed quarter for Novartis
Novartis reported a mixed third quarter on Tuesday, as the pharmaceutical giant lifted its profit outlook for the year but faced disappointing sales in key areas.